Global Nausea Medicine Market Research Report—Forecast till 2027

Global Nausea Medicine Market Research Report—Forecast till 2027

$4450 – $6250

The global Nausea Medicine Market is anticipated to witness a notable CAGR of 7.83% to surpass USD 2423.26 Million by the forecast period of 2027. Nausea medicines are used to treat conditions such as nausea and vomiting.

SKU: MRFR210118 Category: Tags: , , , , , , , , , ,

Description

Global Nausea Medicine Market Research Report—Forecast till 2027

Market Synopsis

The global Nausea Medicine Market is anticipated to witness a notable CAGR of 7.83% to surpass USD 2423.26 Million by the forecast period of 2027. Nausea medicines are used to treat conditions such as nausea and vomiting. The global market growth is attributed to the rising cases of cancer increase in gastrointestinal diseases, and growing geriatric population, sedentary lifestyle, and unhealthy diet.
The global Nausea Medicine Market is expected to register a healthy market growth during the review period owing to the increasing cases of cancer worldwide. The United States has more patients of cancer patients as per the study of the national cancer Institute approximately 1.8 Million people will be diagnosed with cancer in 2020. In 2017, as per the Cancer Research UK, in females in the UK, there were more than 179,000 new cancer cases and in males in the UK, there were around 187,000 new cancer cases that are likely to propel the market in the future. However, a high preference for home remedies is anticipated to restrain the growth of this market during the review period. Furthermore, collaborations between large drug manufacturing companies and small companies are expected to register the lucrative opportunity for the growth of the global Nausea market during the assessment period.
Market Segmentation
Global Nausea Medicine Market has been classified into Type, Mode of Administration, Indication, and Distribution Channel.
Based on the type, the nausea medicine market has been divided into antagonists, cannabinoids, antihistamines, and others. The nausea medicine market, in terms of the mode of administration category, is classified into oral, intravenous, and others. The nausea medicine market, based on indication, is classified into oncology, gastroesophageal reflux disease (GERD), motion sickness, and others. Based on distribution channels the market has been classified into hospital/retail pharmacies and online.
Based on indication, the oncology segment held the largest share of 39.84% in 2019 because of the rising number of patients experiencing nausea associated with chemotherapeutic drug use.
Regional Analysis
Geographically, Global Nausea Medicine Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to lead the global nausea medicine market during the review period owing to the presence of major manufacturers, increasing awareness about early disease diagnosis, and the increasing prevalence of gastrointestinal diseases.
The European market is expected to register as the second-largest market for nausea medicine. The regional market is attributed to the biopharmaceutical sector, improving economies, high disposable income per individual, and increased healthcare spending market in this region.
The market in Asia-Pacific is anticipated to exhibit substantial market growth during the review period because of growing awareness about diseases, government support to improve the healthcare sector, and increasing geriatric population.
Key Players
The Major Players in the Global Nausea Medicine Market are Novartis AG (Switzerland), Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline PLC (UK), Pfizer Inc. (US), Sanofi S.A. (France), Mylan NV (US), AstraZeneca (UK), Cipla Inc. (India), and others.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 1.1 OVERVIEW 14 1.1.1 MARKET SYPNOSIS 14 2 MARKET INTRODUCTION 2.1 DEFINITION 15 2.2 SCOPE OF THE STUDY 15 2.3 RESEARCH OBJECTIVE 15 2.4 MARKET STRUCTURE 15 2.5 ASSUMPTIONS & LIMITATIONS 16 3 RESEARCH METHODOLOGY 3.1 DATA MINING 17 3.2 SECONDARY RESEARCH 18 3.3 PRIMARY RESEARCH 18 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19 3.5 FORECASTING TECHNIQUES 20 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21 3.6.1 BOTTOM-UP APPROACH 22 3.6.2 TOP-DOWN APPROACH 22 3.7 DATA TRIANGULATION 23 3.8 VALIDATION 23 4 MARKET DYNAMICS 4.1 OVERVIEW 24 4.2 DRIVERS 25 4.2.1 GROWING CASES OF CANCER 25 4.2.2 RISE IN GASTROINTESTINAL DISEASES 25 4.2.3 INCREASING GERIATRIC POPULATION, SEDENTARY LIFESTYLE, AND UNHEALTHY DIET 25 4.3 RESTRAINTS 26 4.3.1 HIGH PREFERENCE FOR HOME REMEDIES 26 4.4 OPPORTUNITIES 27 4.4.1 COLLABORATIONS BETWEEN LARGE DRUG MANUFACTURING COMPANY AND SMALL COMPANIES 27 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 28 5.1.1 R&D AND DESIGNING 29 5.1.2 MANUFACTURING 29 5.1.3 DISTRIBUTION & SALES 29 5.1.4 POST-SALES SERVICES 29 5.2 PORTER’S FIVE FORCES MODEL 30 5.2.1 BARGAINING POWER OF SUPPLIERS 31 5.2.2 BARGAINING POWER OF BUYERS 31 5.2.3 THREAT OF NEW ENTRANTS 31 5.2.4 THREAT OF SUBSTITUTES 31 5.2.5 INTENSITY OF RIVALRY 31 6 GLOBAL NAUSEA MEDICINE MARKET, BY TYPE 6.1 OVERVIEW 32 6.2 ANTAGONISTS 33 6.3 ANTIHISTAMINES 33 6.4 CANNABINOIDS 34 6.5 OTHERS 34 7 GLOBAL NAUSEA MEDICINE MARKET, BY MODE OF ADMINISTRATION 7.1 OVERVIEW 35 7.2 INTRAVENOUS 36 7.3 ORAL 36 7.4 TRANSDERMAL 37 8 GLOBAL NAUSEA MEDICINE MARKET, BY INDICATION 8.1 OVERVIEW 38 8.2 ONCOLOGY 39 8.3 GASTROESOPHAGEAL REFLUX DISEASE (GERD) 39 8.4 MOTION SICKNESS AND SEASICKNESS 40 8.5 OTHERS 40 9 GLOBAL NAUSEA MEDICINE MARKET, BY DISTRIBUTION CHANNEL 9.1 OVERVIEW 41 9.2 HOSPITALS PHARMACY/ RETAIL PHARMACY 42 9.3 ONLINE 42 10 GLOBAL NAUSEA MEDICINE MARKET, BY REGION 10.1 OVERVIEW 43 10.2 AMERICAS 44 10.2.1 NORTH AMERICA 46 10.2.1.1 US 48 10.2.1.2 CANADA 49 10.2.2 SOUTH AMERICA 51 10.3 EUROPE 53 10.3.1 WESTERN EUROPE 55 10.3.1.1 GERMANY 57 10.3.1.2 FRANCE 58 10.3.1.3 UK 60 10.3.1.4 ITALY 61 10.3.1.5 SPAIN 62 10.3.1.6 REST OF WESTERN EUROPE 64 10.3.2 EASTERN EUROPE 65 10.4 ASIA-PACIFIC 67 10.4.1 CHINA 69 10.4.2 JAPAN 70 10.4.3 INDIA 72 10.4.4 AUSTRALIA 73 10.4.5 SOUTH KOREA 74 10.4.6 REST OF ASIA-PACIFIC 76 10.5 MIDDLE EAST & AFRICA 78 10.5.1 MIDDLE EAST 80 10.5.2 AFRICA 81 11 COMPETITIVE LANDSCAPE 11.1 OVERVIEW 83 11.2 MAJOR PLAYERS IN THE GLOBAL NAUSEA MEDICINE MARKET 83 11.3 COMPETITIVE BENCHMARKING 84 11.4 COMPETITOR DASHBOARD 85 11.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 85 11.5.1 ACQUISITIONS 85 12 COMPANY PROFILES 12.1 SANOFI S.A. 86 12.1.1 COMPANY OVERVIEW 86 12.1.2 FINANCIAL OVERVIEW 86 12.1.3 PRODUCTS/SERVICES OFFERED 87 12.1.4 KEY DEVELOPMENTS 87 12.1.5 SWOT ANALYSIS 87 12.1.6 KEY STRATEGIES 87 12.2 NOVARTIS AG 88 12.2.1 COMPANY OVERVIEW 88 12.2.2 FINANCIAL OVERVIEW 88 12.2.3 PRODUCTS/SERVICES OFFERED 89 12.2.4 KEY DEVELOPMENTS 89 12.2.5 SWOT ANALYSIS 89 12.2.6 KEY STRATEGIES 89 12.3 MERCK & CO., INC. 90 12.3.1 COMPANY OVERVIEW 90 12.3.2 FINANCIAL OVERVIEW 90 12.3.3 PRODUCTS/SERVICES OFFERED 91 12.3.4 KEY DEVELOPMENTS 91 12.3.5 SWOT ANALYSIS 91 12.3.6 KEY STRATEGIES 91 12.4 GLAXOSMITHKLINE PLC 92 12.4.1 COMPANY OVERVIEW 92 12.4.2 FINANCIAL OVERVIEW 92 12.4.3 PRODUCTS/SERVICES OFFERED 93 12.4.4 KEY DEVELOPMENTS 93 12.4.5 SWOT ANALYSIS 93 12.4.6 KEY STRATEGIES 94 12.5 MYLAN NV 95 12.5.1 COMPANY OVERVIEW 95 12.5.2 FINANCIAL OVERVIEW 95 12.5.3 PRODUCTS/SERVICES OFFERED 96 12.5.4 KEY DEVELOPMENTS 96 12.5.5 SWOT ANALYSIS 96 12.5.6 KEY STRATEGIES 96 12.6 PFIZER INC. 97 12.6.1 COMPANY OVERVIEW 97 12.6.2 FINANCIAL OVERVIEW 97 12.6.3 PRODUCTS/SERVICES OFFERED 98 12.6.4 KEY DEVELOPMENTS 98 12.6.5 SWOT ANALYSIS 98 12.6.6 KEY STRATEGIES 98 12.7 F. HOFFMANN-LA ROCHE LTD 99 12.7.1 COMPANY OVERVIEW 99 12.7.2 FINANCIAL OVERVIEW 99 12.7.3 PRODUCTS/SERVICES OFFERED 100 12.7.4 KEY DEVELOPMENTS 100 12.7.5 SWOT ANALYSIS 100 12.7.6 KEY STRATEGIES 100 12.8 ASTRAZENECA 101 12.8.1 COMPANY OVERVIEW 101 12.8.2 FINANCIAL OVERVIEW 101 12.8.3 PRODUCTS/SERVICES OFFERED 102 12.8.4 KEY DEVELOPMENTS 102 12.8.5 SWOT ANALYSIS 102 12.8.6 KEY STRATEGIES 102 12.9 CIPLA INC. 103 12.9.1 COMPANY OVERVIEW 103 12.9.2 FINANCIAL OVERVIEW 103 12.9.3 PRODUCTS/SERVICES OFFERED 104 12.9.4 KEY DEVELOPMENTS 104 12.9.5 SWOT ANALYSIS 104 12.9.6 KEY STRATEGIES 104 13 APPENDIX 13.1 REFERENCES 105 13.2 RELATED REPORTS 105

Reviews

There are no reviews yet.

Be the first to review “Global Nausea Medicine Market Research Report—Forecast till 2027”

Related products